Almac Dx Plans to Debut Array-based Colorectal Cancer-Recurrence Test Next Year
November 15, 2011
Almac Dx Plans to Debut Array-based Colorectal Cancer-Recurrence Test Next Year
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Almac Diagnostics Sees Benefit for Test Pipeline in New Ovarian, Breast Cancer Studies
June 7, 2011 / BioArray News - After Decade as CRO, Shanghai Biochip Plans Move into Chinese Molecular Dx Market
December 18, 2012 / BioArray News - Team Uses Affy's OncoScan to Develop Prostate Cancer Prognostic Signature, Envisions Clinical Use
October 23, 2012 / BioArray News - 'Provocative' Paper Sparks Debate on Relevance of Breast Cancer Gene Expression Signatures
September 4, 2012 / BioArray News - Almac, Queens University Belfast to Use Xcel Array in $7M Cancer Dx Alliance
September 13, 2011 / BioArray News